DOTmed December 9, 2025
The medtech industry enters 2026 at a defining point. While surgical robotics and digital medicine continue to advance rapidly, the world around them grows more complex. Global uncertainty and supply chain challenges are testing how innovation endures and adapts.
The next phase of minimally invasive surgical robotics will not depend on one breakthrough but on how effectively the industry combines resilience, integration and precision to deliver lasting progress.
Resilience as a core innovation strategy
Geopolitical tension and material shortages have exposed the fragility of traditional supply chains. A recent Medical Product Outsourcing survey found that more than half of medtech leaders cited sourcing and logistics disruptions as their top operational risk heading into 2026.
In surgical robotics, precision components and...
Today's Sponsors
Today's Sponsor